Search research articles
Contact Us
Filters
Showing results (161-170 of 267) with videos related to
Page
of 27
Sort By:
Chest
|
October 8, 2018
Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome
Clément Lejealle, Valérie Paradis, Onorina Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2012
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients
Daniela Speisky, Aurélie Duces, Ivan Bièche, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2021
Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery
Pierre Bel Lassen, Nicole Nori, Pierre Bedossa, et al.
European Journal of Immunology
|
November 23, 2011
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Béziat, Olav Dalgard, Tarik Asselah, et al.
Journal of Hepatology
|
October 11, 2012
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro, Philippe Labrune, Guillaume Morcrette, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Diagnostics (Basel, Switzerland)
|
September 3, 2020
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
Wei-Qiang Leow, Pierre Bedossa, Feng Liu, et al.
Gastroenterology
|
January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J Eddowes, Magali Sasso, Michael Allison, et al.
Plos One
|
March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data
Thierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Genome Biology
|
January 23, 2008
Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity
Corneliu Henegar, Joan Tordjman, Vincent Achard, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 267) with videos related to
Sort By:
Page
of 27
Chest
|
October 8, 2018
Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome
Clément Lejealle, Valérie Paradis, Onorina Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2012
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients
Daniela Speisky, Aurélie Duces, Ivan Bièche, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2021
Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery
Pierre Bel Lassen, Nicole Nori, Pierre Bedossa, et al.
European Journal of Immunology
|
November 23, 2011
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Béziat, Olav Dalgard, Tarik Asselah, et al.
Journal of Hepatology
|
October 11, 2012
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro, Philippe Labrune, Guillaume Morcrette, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Diagnostics (Basel, Switzerland)
|
September 3, 2020
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
Wei-Qiang Leow, Pierre Bedossa, Feng Liu, et al.
Gastroenterology
|
January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J Eddowes, Magali Sasso, Michael Allison, et al.
Plos One
|
March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data
Thierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Genome Biology
|
January 23, 2008
Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity
Corneliu Henegar, Joan Tordjman, Vincent Achard, et al.
Page
of 27